최해웅 연구실

45. Gardnerella piotii enhances uropathogenic Escherichia coli infection through a succinate–GPR91–uroplakin axis. 44. Dual-adjuvant mucosal vaccine leveraging mast cell and TLR9 agonists for protection against poxvirus infection. 43. Excessive Epithelial Mechanosensation Drives Nociceptive Innervation and Chronic Bladder Pain via the PIEZO1–SLC7A11–Glutamate Axis. 42. Selective Inhibition of Integrin β3 Topology Provides a Safer Antithrombotic Strategy. 41. Recombinant haemostatic protein for therapeutic substitution of platelet function via tripartite haemostatic mechanisms in thrombocytopenic male mice. 40. Progression of Sepsis to Septic Shock is Triggered by Platelet Activation of Perivascular Mast Cells. 39. Autophagy-driven MHC-I downregulation enables NK cell-mediated clearance of intracellular uropathogenic E. coli in urinary tract infection. 38. Metabolite-mediated mechanisms linking the urinary microbiome to bladder cancer. 34. Anaphylactic degranulation by mast cells requires the mobilization of inflammasome components. 33. Recurrent infections drive persistent bladder dysfunction and pain via sensory nerve sprouting and mast cell activity. Hayes BW, Choi HW, Rathore AP, Bao C, Shi J, Huh Y, Kim HW, Mencarelli A, Bist P, Ng LG, Shi C, Nho JH, Kim A, Yoon H, Lim D, Hannan JL, Purves JT, Hughes Jr FM, Ji RR, Abraham SN. 32. Stabilization of Activated Mast Cells by ORAI1 Inhibitor Suppresses Peanut-Induced Anaphylaxis and Acute Diarrhea. 30. α-Hemolysin promotes uropathogenic E. coli persistence in bladder epithelial cells via abrogating bacteria-harboring lysosome acidification. 29. Microbiome in urological diseases: Axis crosstalk and bladder disorders. 28. The Urinary Microbiome: Role in Bladder Cancer and Treatment. 27. Lactobacillus crispatus Suppresses Bl